The global High-Performance Liquid Chromatography (HPLC) market is crucial in healthcare, supporting pharmaceutical research, drug development, and clinical diagnostics. HPLC ensures medication safety and effectiveness through compound analysis and quality control measures. In clinical settings, it aids in disease diagnosis, progression monitoring, and drug therapy monitoring. Moreover, HPLC contributes to biomedical research, facilitating the study of complex biological samples and advancements in precision medicine.
Recently, BIS Research released the High-Performance Liquid Chromatography (HPLC) market report, which covers the period from 2023 to 2033, with a base year of 2022. The market size 2023 was $5.23 billion, with a projected value of $8.22 billion by 2033, indicating a compound annual growth rate (CAGR) of 4.61% during the forecast period. The report comprises 144 pages, including 104 tables and 34 figures.
Drivers
• Technological advancements in high-performance liquid chromatography (HPLC)
• Growing adoption of HPLC in drug discovery and development processes
• High sensitivity and accuracy of HPLC
Challenges
• High cost of the HPLC systems
Opportunities
• Increasing use of chromatography in the purification of monoclonal antibodies
• Integration with artificial intelligence (AI) for advanced data analysis and interpretation
Click Here to Download Free Sample
Segmentation 1: by Product
• Instruments
• Consumables
• Accessories
Segmentation 2: by Application
• Clinical Research
• Diagnostic
• Forensics
• Others
Segmentation 3: by Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa
Overview: The global High-Performance Liquid Chromatography (HPLC) market is categorized by products, applications, and regions. Instruments, primarily driven by integrated systems, dominated with a 65.91% share in 2022. Clinical Research-led applications, with a 47.62% share, are projected to maintain dominance. Regionally, the Asia-Pacific market is expected to grow significantly at 5.29% during the forecast period, attributed to rising adoption, technological advancements, and research investments. In 2022, Asia-Pacific held a 20.10% share of the global HPLC market.
• Thermo Fisher Scientific, Inc.
• Merck KGaA
• Shimadzu Corporation
• Waters Corporation
• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• PerkinElmer, Inc.
• Hitachi, Ltd.
• YMC Co. Ltd.
• Restek Corporation
• Gilson, Inc.
• Phenomenex
BIS Principal Analyst: “The current landscape of the HPLC market is dynamic and has been characterized by a shift from rapid expansion to steady maturation. Established companies are embracing innovation, such as miniaturization and automation, to stay competitive, while new entrants are introducing cost-effective alternatives. Growth prospects persist in emerging regions and specialized applications, presenting strategic opportunities. Competition is fierce, emphasizing the importance of differentiation and customer-centric approaches. Although no longer experiencing a frenzy, the HPLC market continues evolving, offering adaptation and innovation prospects. In essence, it has been an ever-changing and stimulating environment.”
Interested to know more about the growing technologies in your industry vertical? Get the latest market studies and insights from BIS Research. Connect with us at [email protected] to learn more.
